HealthEquity
Stock Forecast, Prediction & Price Target
HealthEquity Financial Estimates
HealthEquity Revenue Estimates
HealthEquity EBITDA Estimates
HealthEquity Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 1/31/2022 | 1/31/2023 | 1/31/2024 | 1/31/2026 | 1/31/2027 | ||
Revenue
% change YoY
| $756.55M N/A | $861.74M 13.90% | $999.58M 15.99% | Avg: $1.33B Low: $1.28B High: $1.38B avg. 33.29% | Avg: $1.48B Low: $1.45B High: $1.52B avg. 11.61% | ||
Net Income
% change YoY
| $-44.28M N/A | $-26.14M 40.97% | $55.71M 313.10% | Avg: $177.57M Low: $137.54M High: $232.17M avg. 218.73% | Avg: $240.12M Low: $168.01M High: $477.39M avg. 35.22% | ||
EBITDA
% change YoY
| $171.82M N/A | $171.52M -0.17% | $282.41M 64.64% | Avg: $347.56M Low: $334.59M High: $360.53M avg. 23.06% | Avg: $387.94M Low: $379.77M High: $397.26M avg. 11.61% | ||
EPS
% change YoY
| -$0.53 N/A | -$0.31 41.50% | $0.65 309.67% | Avg: $1.95 Low: $1.58 High: $2.67 avg. 199.51% | Avg: $3.36 Low: $1.93 High: $5.49 avg. 72.48% | ||
Operating Expenses
% change YoY
| $383.13M N/A | $452.43M 18.08% | $401.74M -11.20% | Avg: $251.18M Low: $241.81M High: $260.55M avg. -37.47% | Avg: $280.36M Low: $274.46M High: $287.10M avg. 11.61% | ||
FAQ
What is HealthEquity stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 126.97% in 2026-2027.
We have gathered data from 9 analysts. Their low estimate is 137.54M, average is 177.57M and high is 232.17M.
What is HealthEquity stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 22.45% in 2026-2027.
We have gathered data from 11 analysts. Their low revenue estimate is $1.28B, average is $1.33B and high is $1.38B.
What is HealthEquity stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 136.00% in 2026-2027.
We have gathered data from 9 analysts. Their low earnings per share estimate is $1.58, average is $1.95 and high is $2.67.
What is the best performing analyst?
In the last twelve months analysts have been covering HealthEquity stock. The most successful analyst is Stan Berenshteyn.